IRAK1 and neoplasm: The combination treatment of ginsenoside panaxatriol (GPT) and PTX could inhibit the tumor cells growth and induce apoptosis of TNBC cells resistant to PTX by suppressing interleukin-1 receptor-associated kinase 1 (IRAK1)-mediated NF-κB and ERK pathways [85].